2020 Program Panel Topics Preview
  • Prioritizing Real-World Evidence for Regulatory Discussions
  • New Treatment Approaches for Solid Tumors
  • Cross-Border Deal Making Challenges and Opportunities
  • Innovations in Cardiovascular Drugs
  • New Modalities: Critical Success Factors for Gene and Cell Therapies
  • Expanding Neuroscience Pipeline Target Lists
  • Regulatory Outlook: Lessons for Globalizing Clinical Trials